Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

IM Cannabis Corp (CSE:IMCC)

5.100 UNCHANGED

Last Price Updated: 3:41 PM EDT, Jun 2, 2025 Add to My Watchlist

All News about IM Cannabis Corp

< Previous 1 2 Next >

IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3 ↗

November 14, 2024

International medical cannabis company IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial results for the third quarter ended Sept. 30, 2024. The company reported revenue...

Via Benzinga

Canopy Growth And Other Top Cannabis Companies To Report Earnings: Will Results Get Pot Stocks On Track Following Post-Election Dip? ↗

November 06, 2024

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) will report the second quarter of fiscal year 2025 ended Sept. 30, before financial markets open on Friday, Nov. 8, 2024. IM Cannabis Corp. (CSE:...

Via Benzinga

The Ever-Evolving Cannabis Industry: These Are Latest Leadership Changes You Should Know About ↗

October 10, 2024

The U.S. Hemp Roundtable made headlines in early September as its board of directors welcomed two distinguished leaders from the hemp beverage sector to its officer ranks. New York's chief equity...

Via Benzinga

IM Cannabis' $1.6M Non-Brokered Private Placement Offering, Here's What Investors Need To Know ↗

October 04, 2024

Medical cannabis company with operations in Israel and Germany, IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC), intends to undertake a non-brokered private placement offering of up to $1,613,000 through...

Via Benzinga

How Cannabis Legalization In Germany Boosted This Company's Revenue, Will Spain's Medical Marijuana Framework Do The Same? ↗

October 02, 2024

Spain's Ministry of Health revealed this week a draft royal decree for public consultation, outlining the suggested regulations for prescribing cannabis-based medications, reported Business of...

Via Benzinga

IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY ↗

August 14, 2024

The company, announced its financial results Wednesday for the second quarter ended June 30, 2024, revealing a 12% year-over-year increase in revenue to CA$14.8 million in the second quarter of 2023....

Via Benzinga

IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now ↗

August 06, 2024

Medical cannabis company IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), with operations in Israel and Germany, will report operational and financial results for the second quarter of 2024 ended June 30,...

Via Benzinga

IM Cannabis Announces Major Share Consolidation Plan: What Investors Need To Know ↗

July 05, 2024

IM Cannabis announces a share consolidation effective July 12, aiming to enhance marketability and streamline shares.

Via Benzinga

Global Weed Business: Flora Buys Australian Vaporizers As IM Cannabis Doubles Down On Germany ↗

June 05, 2024

Lifeist Wellness Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF) said on Wednesday the sale of Australian Vaporizers Pty Ltd., its wholly owned Australian subsidiary to Flora Growth Corp. (NASDAQ:...

Via Benzinga

IM Cannabis Doubles Down On Germany Following Legalization Policy Change, Reports YoY Drop In Q1 Gross Profit And Revenue ↗

May 08, 2024

IM Cannabis reported a 13% sequential increase in revenue for the three months ended March 31, 2024, hitting CA$10.7 million ($7.8 million). That is, however, a 4% decrease compared to the same quarter...

Via Benzinga

Avant Brands Bolsters International Growth in German Cannabis Market Through Partnership with IMC

April 04, 2024

Via ACCESSWIRE

IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity ↗

March 28, 2024

IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial and operational results for the year ended Dec. 2023. The Toronto-headquartered medical cannabis company with a focus on...

Via Benzinga

IM Cannabis Stock Drops On Q2 Earnings, CEO Touts Strategic Decisions That Led To 'Sustainable Profitability' ↗

August 14, 2023

IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) reported its second-quarter financial results on Tuesday for the period ending June 30, 2023.

Via Benzinga

Avant Brands and IM Cannabis Announce the Launch of BLK MKT in Israel

October 12, 2022

Via ACCESSWIRE

IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel

January 19, 2022

The successful import demonstrates the strength of the IM Cannabis global supply chain and business model TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 19, 2022 / IM Cannabis Corp. (the...

From IM Cannabis Corp.

Via AccessWire

IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary

January 13, 2022

Oren Shuster remains Chief Executive Officer and Director of IM Cannabis Corp.; other managerial changes include the promotion of Yael Harrosh to Chief Legal and Operations Officer of IM Cannabis Corp....

From IM Cannabis Corp.

Via AccessWire

IM Cannabis to Launch WAGNERS Brand in Germany

December 07, 2021

IM Cannabis expects to export premium, indoor-grown Canadian cannabis in 2022 to the rapidly evolving German medical cannabis market TORONTO, ON, GLIL YAM, ISRAEL and BAD OLDESLOE, GERMANY / ACCESSWIRE...

From IM Cannabis Corp.

Via AccessWire

IM Cannabis To Buy Jerusalem-Based Medical Marijuana Pharmacy For $4.9M In Cash And Stock ↗

December 01, 2021

IM Cannabis Corp. (CSE:IMCC), (NASDAQ:

Via Benzinga

IM Cannabis to Acquire Oranim, Jerusalem's Leading Medical Cannabis Pharmacy

December 01, 2021

Transaction positions IM Cannabis as one of the largest retailers of medical cannabis in Israel; Retail segment combined annualized revenue of approximately $44 million Oranim's trailing 12-month...

From IM Cannabis Corp.

Via AccessWire

IM Cannabis To Debut WAGNERS Brand In Israel After Receiving Regulatory Approval ↗

November 30, 2021

IM Cannabis Corp. (CSE:IMCC) (NASDAQ:

Via Benzinga

IM Cannabis Announces Focus Medical's Receipt of Israeli Ministry of Health Import Permit; Plans to Launch WAGNERS Brand in Israel

November 29, 2021

From IM Cannabis Corp.

Via AccessWire

IM Cannabis Announces Fourth Installment of Shares in Connection with the Panaxia Transaction

November 18, 2021

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 18, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQ:IMCC), a leading medical and adult-use recreational cannabis...

From IM Cannabis Corp.

Via AccessWire

IM Cannabis Announces Third Quarter 2021 Financial Results and Provides Outlook and Business Update

November 15, 2021

Q3 2021 revenues of $14.4 million; a 30% increase from Q2 2021 Gross margin improved to 20% from 5.4% in Q2 2021; expected to increase further in Q4 and into 2022 Canadian recreational brands WAGNERS...

From IM Cannabis Corp.

Via AccessWire

IMC Announces Third Installment of Shares in Connection with the Panaxia Transaction

October 20, 2021

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / October 20, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC, NASDAQ:IMCC), a leading medical and adult-use recreational cannabis...

From IM Cannabis Corp.

Via AccessWire

IMC Provides Further Details on Panaxia Transaction

September 08, 2021

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / September 8, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use...

From IM Cannabis Corp.

Via AccessWire

IM Cannabis Announces Q2 2021 Financial Results and Signing of Definitive Agreement to Acquire Vironna Pharm, Accelerating its Vertical Integration Strategy in Israel

August 16, 2021

Q2 2021 revenues of $11.1 million, a 27% increase from Q1 2021 Acquisition of Vironna pharmacy positions IMC in rapidly growing Arab consumer segment in Israel Following strong start to Q3 across each...

From IM Cannabis Corp.

Via AccessWire

IMC Partners with Leading US Brand to Launch cbdMD Products in Israel and Provides Further Details on Panaxia Transaction

August 09, 2021

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 9, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use...

From IM Cannabis Corp.

Via AccessWire

IMC Announces Results of its Annual General and Special Meeting of Shareholders

August 03, 2021

TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 3, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use...

From IM Cannabis Corp.

Via AccessWire

IMC Accelerates its Israeli Retail Position through Acquisition of Leading Retailer and Distributor Pharm Yarok and Rosen High Way

July 28, 2021

- Strategically located, best in class retailer with approximately CAD$8 million in annualized revenue - Purchase price of CAD$4.6 million TORONTO, ON, GLIL YAM and NATANYA, ISRAEL / ACCESSWIRE / July...

From IM Cannabis Corp.

Via AccessWire

IM Cannabis Provides Update on German Operations and Financial Outlook

July 23, 2021

TORONTO, ON, BAD OLDESLOE, GERMANY, and GLIL YAM, ISRAEL / ACCESSWIRE / July 23, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the...

From IM Cannabis Corp.

Via AccessWire

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.